UNSPSC 51362201: Aceburic acid

This classification denotes an industrial aid, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F777XEP0LL. European Medicines Agency schedules Aceburic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07370MIG. Aceburic acid generally arises in the molecular formula C6H10O4. The term ACEBURIC ACID is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 27, no. 10 1973, list 13.) Most nations schedule aceburic acid under HS 29181985 and SITC 51392.

As of Q4 2014, ACEBURIC ACID remains the US FDA Preferred Term for this commodity. Aceburic acid bears US NLM identifiers UMLS ID C2346942 and NCI Concept Code C72093. SMILES: CC(=O)OCCCC(=O)O.

UNSPSC 51362201 Aceburic acid is a Commodity code that does not align with the state and local procurement activity currently tagged under it. The three recent opportunities in the system show little relevant activity: Seminole County's bid for naloxone and drug deactivation systems, Texas HHS's exploratory RFI on direct-to-manufacturer pharmacy programs, and the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products. None of these solicitations concern aceburic acid or chemical compounds in that family. The mismatch suggests either a data classification error or that aceburic acid—a pharmaceutical intermediate—sees no current state and local procurement demand worth capturing in active opportunities.

The issuing bodies active in the pharmaceutical and health-product space under this code tag include county health departments (Seminole County, Florida), state health and human services agencies (Texas HHS Commission), and multistate cooperative purchasing alliances (MMCAP, administered by Minnesota). Geographic activity centers on Florida, Texas, and the multistate MMCAP network serving state and local facilities across participating jurisdictions including Oregon. Because the recent opportunities are misaligned with the Commodity code itself, pursuing this code requires direct outreach to county health departments and state pharmacy benefit programs to determine whether aceburic acid specifications appear in their active requirements, rather than relying on posted solicitation activity to signal demand.